Zusammenfassung
Eine Thrombose ist definiert als völliger oder partieller Verschluss eines Blutgefäßes durch ein Blutgerinnsel; eine Thromboembolie als Obstruktion eines Gefäßes durch Thrombusanteile, die sich an anderer Stelle im Organismus gebildet haben und von dort disloziert sind. Spontane Thrombosen sind Gefäßverschlüsse ohne zugrunde liegende Begleiterkrankung (exogene Risikofaktoren), von sekundären Thrombosen spricht man, wenn ein Gefäßverschluss auf dem Boden von Begleiterkrankungen, therapeutischen Interventionen oder nach Medikamentengabe entsteht.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Nowak-Göttl U, Kosch A, Schlegel N (2001) Thromboembolism in newborns, infants and children. Thromb Haemost 86:464–474
Andrew M, David M, Adams M et al (1994) Venous thromboembolic complications (VTE) in children: first analyses of the Canadian registry of VTE. Blood 83:1251–1257
Schmidt B, Andrew M (1995) Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics 96:939–943
Nowak-Göttl U, von Kries R, Göbel U (1997) Neonatal symptomatic thromboembolism in Germany: two year survey. Arch Dis Child Fetal Neonatal Ed 76: F163–F167
Massicotte MP, Dix D, Monagle P, Adams M, Andrew M (1998) Central venous catheter related thrombosis in children: Analysis of the Canadian Registry of venous thromboembolic complications. J Pediatr 133:770–776
Van Ommen CH, Heijboer H, Buller HR, Hirasing RA, Heijmans HS, Peters M (2001) Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands. J Pediatr 139:676–681
DeVeber G, Andrew M, Adams C et al (2001) Cerebral sinovenous thrombosis in children. N Engl J Med 345:417–423
Roy M, Turner-Gomes S, Gill G, Way C, Mernagh J, Schmidt B (2002) Accuracy of Doppler echocardiography for the diagnosis of thrombosis associated with umbilical venous catheters. J Pediatr 140:131–134
Male C, Chait P, Ginsberg JS et al (2002) Comparison of venography and ultrasound for the diagnosis of asymptomatic deep vein thrombosis in the upper body in children: Results of the PARKAA study. Thromb Haemost 87:593–659
Junker R, Koch HG, Auberger K, Münchow N, Ehrenforth S, Nowak-Göttl U (1999) Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia. Arterioscler Thromb Vasc Biol 19:2568–2572
Richtlinien zur prädiktiven genetischen Diagnostik. Deutsches ärzteblatt 100(19): A1297–1305, B1085–1093, C1013–1021
Nowak-Göttl U, Junker R, Hartmeier M et al (1999) Increased lipoprotein (a) is an important risk factor for venous thromboembolism in childhood. Circulation 100:743–748
Lane DA, Manucci PM, Bauer KA et al (1996) Inherited thrombophilia: Part 2. Thromb Haemost 76:824–834
Manco-Johnson MJ, Grabowski EF, Hellgreen M et al (2002) Laboratory testing for thrombophilia in pediatric patients. Thromb Haemost 88:155–156
Ehrenforth S, Junker R, Koch HG et al (1999) Multicentre evaluation of combined prothrombotic defects associated with thrombophilia in childhood. Eur J Pediatr 158:S97–S104
Monagle P, Adams M, Mahoney M et al (2000) Outcome of pediatric thromboembolic disease: a report from the Canadian childhood thrombophilia registry. Pediatr Res 47:763–766
Nowak-Göttl U, Junker R, Kreuz W et al (2001) Risk of recurrent thrombosis in children with combined prothrombotic risk factors. Blood 97:858–862
Andrew M, Michelson AD, Bovill E, Leaker M, Massicotte MP (1998) Guidelines for antithrombic therapy in pediatric patients. J Pediatr 132:576–588
Manco-Johnson MJ, Grabowski EF, Hellgreen M et al (2002) Recommendations for tPA thrombolysis in children. Thromb Haemost 88:157–158
Farnoux C, Camard O, Pinquier D et al (1998) Recombinant tissue-type plasminogen activator therapy of thrombosis in 16 neonates. J Pediatr 133:137–140
Weiner GM, Castle VP, DiPietro MA, Faix RG (1998) Successful treatment of neonatal arterial thromboses with recombinant tissue plasminogen activator. J Pediatr 133:133–136
Jacobs BR, Haygood M, Hingl J (2001) Recombinant tissue plasminogen activator in the treatment of central venous catheter occlusion in children. J Pediatr 139:593–596
Choi M, Massicotte MP (2001) The use of alteplase to restore patency of central venous lines in pediatric patients: A cohort study. J Pediatr 139:152–156
Massicotte MP, Adams M, Marzinotto V, Brooker LA, Andrew M (1996) Low-molecular-weight heparin in pediatric patients with thrombotic disease: A dose finding study. J Pediatr 128:313–318
Dix D, Andrew M, Marzinotto V, et al (2000) The use of low molecular weight heparin in pediatric patients: a prospective cohort study. J Pediatr 136:439–445
Hofmann S, Knoefler R, Lorenz N et al (2001) Clinical experience with low-molecular weight heparins in pediatric patients. Thromb Res 103:345–353
Nohe N, Flemmer A, Rümler R, Praun M, Auberger K (1999) The low molecular weight heparin dalteparin for prophylaxis and therapy of thrombosis in childhood: a report of 48 cases. Eur J Pediatr 158:S134–S139
Schmugge M, Risch L, Huber AR, Benn A, Fischer JE (2002) Heparin-induced thrombocytopenia-associated thrombosis in pediatric intensive care patients. Pediatrics 109:U69–U72
Zöhrer B, Zenz W, Rettenbacher A et al (2001) Danaparoid sodium (Orgaran® in four children with heparin-induced thrombocytopenia type II. Acta Paediatr 90: 765–767
Manco-Johnson MJ, Nuss R, Hays T, Krupski W, Drose J, Manco-Johnson ML (2000) Combined thrombolytic and anticoagulant therapy for venous thrombosis in children. J Pediatr 136:446–453
Gupta AA, Leaker M, Andrew M et al (2001) Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children. J Pediatr 139:682–688
Marlar RA, Mongomery RR, Broekmans AW (1989) Diagnosis and treatment of homozygous protein C-deficiency. Report of the Working Party on Homozygous Protein C Deficiency of the Subcommittee on Protein C and Protein S. International Committee on Thrombosis and Haemostasis. J Pediatr 114:528–534
Bernard GR, Vincent JL, Laterre PF et al (2001) Efficacy and Safety of recombinant human activated protein C for sepsis. N Eng J Med 344:699–709
Streif W, Andrew M, Marzinotto V, Massicotte P et al (1999) Analysis of warfarin therapy in pediatric patients: a prospective cohort study of 319 patients. Blood 94:3007–3014
Massicotte P, Marzinotto V, Vegh P, Adams M, Andrew M (1995) Home monitoring of warfarin therapy in children with a whole blood prothrombin time monitor. J Pediatr 127:389–394
Brenner BR, Nowak-Göttl U, Kosch A, Manco-Johnson M, Laposta M (2002) Diagnostic studies for thrombophilia in women on hormonal therapy and during pregnancy, and in children. Arch Pathol Lab Med 126:1296–1303
Carcao MD, Blanchette VS, Dean JA et al (1998) The platelet function analyser (PFA-100): a novel in-vitro system for evaluation of primary haemostasis in children. Br J Haematol 101:70–73
Hathaway WE (1984) Use of antiplatelet agents in pediatric hypercoagulable states. Am J Dis Child 138:301–304
Sträter R, Kurnik K, Heller C, Schobess R, Luigs P, Nowak-Göttl U (2001) Aspirin versus low-dose low-molecular-weight heparin: Antithrombotic therapy in pediatric stroke patients. A prospective follow-up study. Stroke 32:2554–2558
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Nowak-Göttl, U. et al. (2010). Thrombosen im Kindesalter. In: Pourhassan, S., Sandmann, W. (eds) Gefäßerkrankungen im Kindes- und Jugendalter. Steinkopff. https://doi.org/10.1007/978-3-7985-1760-8_11
Download citation
DOI: https://doi.org/10.1007/978-3-7985-1760-8_11
Publisher Name: Steinkopff
Print ISBN: 978-3-7985-1759-2
Online ISBN: 978-3-7985-1760-8
eBook Packages: Medicine (German Language)